ArticleCancer immunology, immunotherapy : CII2023

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma.

Jun Takei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.